Production of Factor VIII by Human Liver Sinusoidal Endothelial Cells Transplanted in Immunodeficient uPA Mice
Open Access
- 22 October 2013
- journal article
- clinical trial
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10), e77255
- https://doi.org/10.1371/journal.pone.0077255
Abstract
Liver sinusoidal endothelial cells (LSECs) form a semi-permeable barrier between parenchymal hepatocytes and the blood. LSECs participate in liver metabolism, clearance of pathological agents, immunological responses, architectural maintenance of the liver and synthesis of growth factors and cytokines. LSECs also play an important role in coagulation through the synthesis of Factor VIII (FVIII). Herein, we phenotypically define human LSECs isolated from fetal liver using flow cytometry and immunofluorescence microscopy. Isolated LSECs were cultured and shown to express endothelial markers and markers specific for the LSEC lineage. LSECs were also shown to engraft the liver when human fetal liver cells were transplanted into immunodeficient mice with liver specific expression of the urokinase-type plasminogen activator (uPA) transgene (uPA-NOG mice). Engrafted cells expressed human Factor VIII at levels approaching those found in human plasma. We also demonstrate engraftment of adult LSECs, as well as hepatocytes, transplanted into uPA-NOG mice. We propose that overexpression of uPA provides beneficial conditions for LSEC engraftment due to elevated expression of the angiogenic cytokine, vascular endothelial growth factor. This work provides a detailed characterization of human midgestation LSECs, thereby providing the means for their purification and culture based on their expression of CD14 and CD32 as well as a lack of CD45 expression. The uPA-NOG mouse is shown to be a permissive host for human LSECs and adult hepatocytes, but not fetal hepatoblasts. Thus, these mice provide a useful model system to study these cell types in vivo. Demonstration of human FVIII production by transplanted LSECs encourages further pursuit of LSEC transplantation as a cellular therapy for the treatment of hemophilia A.Keywords
This publication has 44 references indexed in Scilit:
- Coexpression of CD14 and CD326 Discriminate Hepatic Precursors in the Human Fetal LiverStem Cells and Development, 2011
- Inductive angiocrine signals from sinusoidal endothelium are required for liver regenerationNature, 2010
- Repopulation Efficiencies of Adult Hepatocytes, Fetal Liver Progenitor Cells, and Embryonic Stem Cell-Derived Hepatic Cells in Albumin-Promoter-Enhancer Urokinase-Type Plasminogen Activator MiceThe American Journal of Pathology, 2009
- Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerizationHepatology, 2008
- Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull miceBiochemical and Biophysical Research Communications, 2008
- Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A miceJCI Insight, 2008
- Human hepatic stem cells from fetal and postnatal donorsThe Journal of Experimental Medicine, 2007
- VEGF is crucial for the hepatic vascular development required for lipoprotein uptakeDevelopment, 2005
- Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact miceHepatology, 2005
- Endothelial cell heterogeneity in the normal human liver acinus: in situ immunohistochemical demonstrationLiver International, 1994